OPKO Health, Inc. (OPK) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Lifestance Health Group, Inc.

Azenta, Inc.

Hims & Hers Health, Inc.

Addus HomeCare Corp.

RadNet, Inc.

Teladoc Health, Inc.

NeoGenomics, Inc.

U.S. Physical Therapy, Inc.

Ginkgo Bioworks Holdings, Inc.

OPKO Health, Inc.

Celldex Therapeutics, Inc.

Why is OPKO Health, Inc. ?

Poor Management Efficiency with a low ROCE of 1.42%

The company has been able to generate a Return on Capital Employed (avg) of 1.42% signifying low profitability per unit of total capital (equity and debt)

Poor long term growth as Net Sales has grown by an annual rate of -11.23% over the last 5 years

NET PROFIT(HY) At USD -127.27 MM has Grown at -970%
INTEREST(HY) At USD 81.69 MM has Grown at 219.84%
OPERATING CASH FLOW(Y) Lowest at USD -197.03 MM

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of -37.57%, its profits have fallen by -73.7%

Below par performance in long term as well as near term

Along with generating -37.57% returns in the last 1 year, the stock has also underperformed S&P 500 in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is OPKO Health, Inc. for you?

Medium Risk, Low Return

Absolute

Risk Adjusted

Volatility

OPKO Health, Inc.

-34.25%

-0.35

37.39%

S&P 500

13.68%

0.71

19.28%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-11.23%

EBIT Growth (5y)

-244.42%

EBIT to Interest (avg)

-6.73

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

0.01

Sales to Capital Employed (avg)

0.44

Tax Ratio

100.00%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

32.22%

ROCE (avg)

1.42%

ROE (avg)

1.40%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

0.72

EV to EBIT

-4.12

EV to EBITDA

-7.30

EV to Capital Employed

0.71

EV to Sales

1.37

PEG Ratio

Dividend Yield

ROCE (Latest)

-17.16%

ROE (Latest)

-14.31%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

No Trend

Mildly Bearish

OBV

No Trend

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

9What is working for the Company

PRE-TAX PROFIT(Q)

At USD 41.14 MM has Grown at 196.44%

NET PROFIT(Q)

At USD 21.48 MM has Grown at 146.86%

RAW MATERIAL COST(Y)

Fallen by -83.95% (YoY

CASH AND EQV(HY)

Highest at USD 686.92 MM

DEBT-EQUITY RATIO (HY)

Lowest at -1.51 %

EPS(Q)

Highest at USD 0.03

-22What is not working for the Company

NET PROFIT(HY)

At USD -127.27 MM has Grown at -970%

INTEREST(HY)

At USD 81.69 MM has Grown at 219.84%

OPERATING CASH FLOW(Y)

Lowest at USD -197.03 MM

INVENTORY TURNOVER RATIO(HY)

Lowest at 7.95 times

DEBTORS TURNOVER RATIO(HY)

Lowest at 4.88 times

NET SALES(Q)

At USD 151.67 MM has Fallen at -8.63%

Here's what is working for OPKO Health, Inc.

Pre-Tax Profit

At USD 41.14 MM has Grown at 196.44%

over average net sales of the previous four periods of USD -42.66 MM

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (USD MM)

Net Profit

At USD 21.48 MM has Grown at 146.86%

over average net sales of the previous four periods of USD -45.84 MM

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (USD MM)

EPS

Highest at USD 0.03

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (USD)

Cash and Eqv

Highest at USD 686.92 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is improving

Cash and Cash Equivalents

Debt-Equity Ratio

Lowest at -1.51 %

in the last five Semi-Annual periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Raw Material Cost

Fallen by -83.95% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for OPKO Health, Inc.

Interest

At USD 81.69 MM has Grown at 219.84%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Operating Cash Flow

Lowest at USD -197.03 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (USD MM)

Net Sales

At USD 151.67 MM has Fallen at -8.63%

over average net sales of the previous four periods of USD 166 MM

MOJO Watch

Near term sales trend is negative

Net Sales (USD MM)

Inventory Turnover Ratio

Lowest at 7.95 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Debtors Turnover Ratio

Lowest at 4.88 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio